South African billionaire Johann Rupert’s Remgro to take full Mediclinic control
Johann Rupert’s Remgro plans a major restructuring to gain full control of Mediclinic Southern Africa.
Skip to content
Johann Rupert’s Remgro plans a major restructuring to gain full control of Mediclinic Southern Africa.
Johann Rupert’s Remgro stake rises $100 million as shares climb, highlighting his influence in South Africa’s investment sector.
Johann Rupert’s Remgro gets Competition Commission approval for eMedia Holdings to acquire full control of eMedia Investments.
Rupert’s Remgro to unbundle eMedia Holdings shares in a move aimed at streamlining media holdings and boosting shareholder value through direct exposure.
The decline has sparked debate, with Remgro recently valuing Maziv at $2.8 billion, outpacing even larger rivals like Telkom.
The revenue growth was bolstered by a 2.3 percent rise in inpatient admissions and a 2.1 percent uptick in day cases.
Ranked as Africa’s second-richest man and South Africa’s wealthiest individual, Rupert maintains significant control over Remgro Limited.
Malherbe’s role as a non-executive deputy chairman of Remgro has positioned him as one of the company’s top individual shareholders.
Remgro Limited is a leading investment holding company led by South Africa’s richest man Johann Rupert.
The market value of Rupert’s stake in Richemont fell rom $7.71 billion to $7.54 billion in December alone.
Grindrod Limited is owned in part by Remgro Limited, Rupert’s investment holding.